MYCN, MYCN proto-oncogene, bHLH transcription factor, 4613
N. diseases: 314; N. variants: 21
Source: ALL
Variant | Gene | Disease | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
0.010 | GeneticVariation | BEFREE | N-myc(T58A) cerebellar and brain stem NSCs generated medulloblastoma/primitive neuroectodermal tumors, whereas forebrain NSCs developed diffuse glioma. | 22624711 | 2012 | |||||||
|
|
|
0.010 | GeneticVariation | BEFREE | N-myc(T58A) cerebellar and brain stem NSCs generated medulloblastoma/primitive neuroectodermal tumors, whereas forebrain NSCs developed diffuse glioma. | 22624711 | 2012 | |||||||
|
|
|
0.010 | GeneticVariation | BEFREE | N-myc(T58A) cerebellar and brain stem NSCs generated medulloblastoma/primitive neuroectodermal tumors, whereas forebrain NSCs developed diffuse glioma. | 22624711 | 2012 | |||||||
|
|
|
0.010 | GeneticVariation | BEFREE | N-myc(T58A) cerebellar and brain stem NSCs generated medulloblastoma/primitive neuroectodermal tumors, whereas forebrain NSCs developed diffuse glioma. | 22624711 | 2012 | |||||||
|
|
|
0.010 | GeneticVariation | BEFREE | N-myc(T58A) cerebellar and brain stem NSCs generated medulloblastoma/primitive neuroectodermal tumors, whereas forebrain NSCs developed diffuse glioma. | 22624711 | 2012 | |||||||
|
|
|
0.010 | GeneticVariation | BEFREE | The results showed that only rs57961569 G>A was associated with neuroblastoma risk (GA vs GG: adjusted odds ratio =0.76, 95% confidence interval =0.60-0.98, <i>P</i>=0.033), while the other 3 SNPs were not (rs9653226 T>C, rs13034994 A>G, and rs60226897 G>A). | 29997440 | 2018 | |||||||
|
|
|
0.010 | GeneticVariation | BEFREE | The results showed that only rs57961569 G>A was associated with neuroblastoma risk (GA vs GG: adjusted odds ratio =0.76, 95% confidence interval =0.60-0.98, <i>P</i>=0.033), while the other 3 SNPs were not (rs9653226 T>C, rs13034994 A>G, and rs60226897 G>A). | 29997440 | 2018 | |||||||
|
|
|
0.010 | GeneticVariation | BEFREE | The results showed that only rs57961569 G>A was associated with neuroblastoma risk (GA vs GG: adjusted odds ratio =0.76, 95% confidence interval =0.60-0.98, <i>P</i>=0.033), while the other 3 SNPs were not (rs9653226 T>C, rs13034994 A>G, and rs60226897 G>A). | 29997440 | 2018 | |||||||
|
|
|
A | 0.800 | CausalMutation | CLINVAR | Genotype-phenotype correlations in MYCN-related Feingold syndrome. | 18470948 | 2008 | ||||||
|
|
|
A | 0.800 | CausalMutation | CLINVAR | |||||||||
|
|
|
A | 0.800 | CausalMutation | CLINVAR | Genotype-phenotype correlations in MYCN-related Feingold syndrome. | 18470948 | 2008 | ||||||
|
|
|
A | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
A | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
A | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
A | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
ACTCG | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
ACTCG | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
ACTCG | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
ACTCG | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
C | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
C | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
C | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
C | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
C | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
C | 0.700 | CausalMutation | CLINVAR |